INMUNE BIO INC. Obligation with Joint and Several Liability Arrangement, Amount Receivable
INMUNE BIO INC. (INMB) had Obligation with Joint and Several Liability Arrangement, Amount Receivable of $49.33 thousand as of 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Notes › Debt
us-gaap:ObligationWithJointAndSeveralLiabilityArrangementAmountReceivable · last filed 2020-03-11
- 2019-06-30: Obligation with Joint and Several Liability Arrangement, Amount Receivable $49.33K.
- 2019-03-31: Obligation with Joint and Several Liability Arrangement, Amount Receivable $34.52K.
- 2018-12-31: Obligation with Joint and Several Liability Arrangement, Amount Receivable $17.99K.
- 2017-12-31: Obligation with Joint and Several Liability Arrangement, Amount Receivable $109.12K.
| Period end | Obligation with Joint and Several Liability Arrangement, Amount Receivable |
|---|---|
| 2019-06-30 | $49.33K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $34.52K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $17.99K 10-K · filed 2020-03-11 |
| 2017-12-31 | $109.12K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |